<!-- about -->
<?php include('../deepPageHeader.php'); ?>
<style>
    
    .first {
padding-top: 20px;
margin-top: 0;
	}
    
   .leftImg{
	float: left;
	margin: 5px 10px 5px 0;
	background: #eee;
	

	}

hr.management {
  padding: 0;
  border: none;
  border-top: 1px solid #808080;
  color: #808080;
  text-align: center;
}
hr.management:after {
  content: "Management";
  display: inline-block;
  position: relative;
  top: -0.7em;
  font-size: 1em;
  font-weight: bold;
  padding: 0 0.75em;
  background: white;
}
    hr.advisory {
  padding: 0;
  border: none;
  border-top: 1px solid #808080;
  color: #808080;
  text-align: center;
}
hr.advisory:after {
  content: "Advisory Committee";
  display: inline-block;
  position: relative;
  top: -0.7em;
  font-size: 1em;
  font-weight: bold;
  padding: 0 0.75em;
  background: white;
}

   .img {
  display: block;
  margin-left: auto;
  margin-right: auto;
}

</style>
	<div class="row">
		<div class="col-sm-12">
			<div class="banner">
				<img src="../images/heroes/about_contact.jpg" alt="hero image">
			</div>
		</div>	
	</div>	
	
	<div class="row">
		<div class="col-xs-12">

	<hr class="management">
       
<img src="../images/headshots1/knockeD.jpg"  class="leftImg" width="140" height="190" alt="Dennis R. Knocke" />
<h4>Dennis R. Knocke, Chief Executive Officer and Chairman of the Board of Directors</h4>  
<p class="first">Mr. Knocke attended Sam Houston State University in Huntsville, Texas. He has successfully founded and operated several start-up healthcare companies that were acquired by national and international business entities listed on the New York and London stock exchanges. Mr. Knocke was previously President of Bexar Credentials Verification, Inc., a start-up software technology company whose principals included the Bexar County Medical Society, the Texas Medical Liability Trust, and Florida Physicians Insurance Company.</p>
<br/><br/>  

                        
<img src="../images/headshots1/nesterJ.jpg" class="leftImg" width="140" height="190" alt="Joseph B. Nester" />
<h4>Joseph B. Nester, Executive Vice President and Sec.-Treasurer</h4>
<p class="first">Mr. Nester graduated from the University of Texas at Austin with a BBA in General Business. He has over 23 years experience in the financial service industry as well as four years experience with a start-up pharmaceutical company, where he was initially the Secretary Treasurer and after four months was named the President. During this time, he led Anvirzel™ in a successful Phase I clinical study, implemented a Compassionate Use Investigational New Drug (CUIND) program, and had direct involvement with the FDA, among other regulatory agencies.</p><br/><br/>  
            
<img src="../images/headshots1/lorijones.jpg" class="leftImg" width="140" height="190" alt="Joel E. Curtis" />            
<h4>Lori Jones, Chief Financial Officer</h4>
<p class="first">Ms. Jones has more than 25 years’ experience in finance and accounting with both private and publicly held entities.  She has served as Chief Financial Officer and other executive level positions in various industries including biotech, manufacturing, and technology.   Those position included, in part, service as Vice President of Finance of CeloNova BioSciences, Inc, a global medical device manufacturer, CFO of Analytical Surveys, Inc., a publicly traded geo-spatial mapping company, and was a partner in Tatum CFO, LLP.   Ms. Jones is a CPA and holds an MBA from the University of Texas at San Antonio. </p><br/><br/>
            
<h4> Richard Boxer, Director</h4><br/>
<p>Mr. Boxer holds a B.A., from Queens University, Kingston, an M.B.A from York University, Toronto and is a Chartered Accountant. His career began with Clarkson Gordon (now Ernst &amp; Young) and moved to the private business sector. During his business career he served as President of Waldec of Canada (a manufacturing company), acted as financial agent in a variety of equity transactions, founded and started a venture capital fund specializing in bridge loans, and has functioned as an angel investor in numerous business sectors. Presently Mr. Boxer is involved as a Director and a shareholder in Falls Management Company, which has built and is now managing an $800,000,000 casino in Niagara Falls, Ontario. He currently serves as President of Buckingham Capital Corporation, a privately owned Canadian merchant bank. Buckingham and an associated company, Rosmir Capital is involved in equity and debt financing, either as an agent or as a principal.</p>
            
<h4>John F. O’Donnell, Director</h4><br/>
<p>Mr. O’Donnell obtained a Bachelor of Arts (Economics) and a Bachelor of Laws from the University of Windsor. He has practiced law in the City of Toronto since 1973 and is counsel to Stikeman Keeley Spiegel Pasternack LLP. His practice is primarily in the field of corporate and securities law and, as such, he is and has been counsel to several publicly traded companies. Mr. O’Donnell is currently also a director as well as Chairman of the Board of RX Exploration Inc.</p>

<h4>J. Peter Nettelfield, Honorary/Founding Director (2007-2012) </h4><br/>
<p>Mr. Nettelfield attended the University of Manitoba in Winnipeg and prior to graduation joined the prestigious Canadian investment banking firm of Wood Gundy &amp; Company, Limited. During his time there he assisted in the initial development of the Canadian money market. After 10 years with Wood Gundy, Mr. Nettelfield’s interest changed from fixed income securities to equities. He then joined Burns Bros. &amp; Denton, noted for its excellent research department. Mr. Nettelfield serviced major institutions and commercial accounts. While at Burns Bros., at the invitation of Sir John Templeton, he became a director of the Templeton Growth Fund. Upon leaving the investment business, he moved to Texas where he became the president of the Texas subsidiary of a Canadian real estate development firm. In this capacity, he oversaw commercial development in Dallas, Austin, and San Antonio. In recent years, he has been active in various entrepreneurial endeavors. While Mr. Nettelfield has been a resident of Texas for over 30 years, he is proud of his Canadian heritage and has retained his Canadian citizenship.</p>
            
<h4> Kerry Mitchell, Director</h4><br/>
 <p>Ms. Mitchell completed the Executive Program at the Tuck School of Business at Dartmouth College in New Hampshire. She is a sought after speaker in Canada and the U.S. on topics including Media, Leadership,Branding, Marketing to Women, and Women in Business. She provides extensive experience as an executive with a strong record of building and transforming multi-platform media brands that include some of the most iconic names in Canadian publishing. Her extensive leadership experience in brand development, marketing and sales, including in the cosmetics, fashion, and lifestyle industries, will be a great benefit to the development and marketing of Nerium’s consumer products.</p>
       
<h4>John Christopher Counsel Wansbrough, Director (Retired 2016)</h4><br/>
<p>Mr. Wansbrough holds a B.A., from the University of Toronto, and is a Chartered Financial Analyst. His career began with the prestigious Canadian investment banking firm of Wood Gundy &amp; Company, Limited. After 7 years with Wood Gundy he joined National Trust Company Limited, were he served as President of National Trust Company from 1977 to 1986, Vice Chairman from 1986 to 1991 and Lead Director through 1995. Mr. Wansbrough has also served as Chairman of the Board of OMERS Realty Corporation from 1989 to 1997, Chairman of the R.S. McLaughlin Foundation from 1994 to 2007, and currently serves as Chairman of Rogers Telecommunications Limited from 1997 to the present. His service as a director to many additional business and community affiliations are too numerous to list.</p>

<hr class="advisory"> 
<h4>Gustavo Ulloa, Jr., Director</h4><br/>
<p>Mr. Ulloa is General Manager and Director for Laboratorios Francelia, a pharmaceutical laboratory and manufacturing facility located in Tegucigalpa, Honduras. The GMP clean room of Nerium is located inside this facility. He is also Country Sales Manager and Director for Distribuidora Francelia, an import and distribution firm focusing on pharmaceuticals, disposables, hospital equipment, and related items. Mr. Ulloa attended the University of Miami where he studied Industrial Engineering. In his various capacities, he interacts with governmental agencies and private entities throughout Central America. Mr. Ulloa is a member of various pharmaceutical trade and producers organizations. He is presently involved in free trade negotiations related to pharmaceuticals between various Central American countries.</p>


<h4>Robert A. Newman, Ph.D., Scientific Advisor</h4><br/>
<p>Dr. Newman obtained his M.S. and Ph.D. degrees in Pharmacology and Toxicology from the University of Connecticut and then served in postdoctoral positions at the Medical School of the University of Georgia as well as the Department of Biochemistry at the University of Vermont. He served as a faculty member at the University of Vermont Medical School for seven years and then spent a sabbatical year at Stanford University performing research on immune targeted therapy. He has spent the last 24 years at the University of Texas M. D. Anderson Cancer Center in Houston, Texas where he served as the founder and Co-Director of the Pharmaceutical Development Center. He has published over 270 articles dealing with the pharmacology, toxicology and development of anticancer drugs. Dr. Newman has recently retired (September 1, 2008) from M. D. Anderson, but remains actively involved in continuing research as Scientific Advisor to NBI.</p>
            
<h4>Richard A. Evans, M.D., Medical Advisor</h4><br/>
<p>Dr. Evans currently is in General Practice, Cancer Consultation, and Medical Writing in Houston, Texas. He is a Diplomate of The American Board of Surgery. Dr. Evans worked with the late Dr. J. S. Stehlin, Jr., founder of the Stehlin Foundation, a world renowned cancer research facility located in Houston, Texas, and is co-author with Dr. Stehlin of several medical treatises dealing with cancer. Additionally, Dr. Evans is a prolific author in his own right publishing many articles on cancer and related immunology. Dr. Evans brings a comprehensive set of skills with him that NBI believes will enable us to integrate, evaluate, and analyze the relationship between oncogenesis and immune response both in the treatment of a naïve patient and the patient receiving various therapeutic agents.</p>
            
<h4>Keith I. Block, M.D., Medical Advisor</h4><br/>
<p>Dr. Block is an internationally recognized integrative cancer-care specialist and visiting lecturer. As Medical Director of the Block Center for Integrative Cancer Care in Evanston, Illinois, the Block Center is committed to caring for people with cancer and improving total wellness through the integration of research-based complementary therapies with innovative approaches to conventional medicine. Dr. Block is the Director of Integrative Medical Education and the Clinical Assistant Professor, Department of Medical Education for the College of Medicine, University of Illinois at Chicago. While too numerous to list all governmental, teaching, and professional appointments here, Dr. Block is Editor-In-Chief of Integrated Cancer Therapies, Sage Science Press, a Member of The Editorial Board for Physician Data Query, CAM, National Cancer Institute, Bethesda, Maryland, and Scientific Director of the Institute for Integrative Cancer Research and Education. He brings first-hand clinical knowledge of Anvirzel™ and its effects through his observations of patients receiving Anvirzel™ therapy.</p>
            
<h4>Donald E. Baxter, M.D., International Medical Advisor</h4><br/>
<p>Dr. Baxter is an internationally renowned and board-certified orthopedic surgeon with a private practice in Houston, Texas. He has been a Clinical Professor of Orthopedic Surgery at both Baylor College of Medicine and the University of Texas Health Science Center. While too numerous to list here, Dr. Baxter is the author of many papers and books. He is also an international and visiting lecturer. Additionally, Dr. Baxter is a past president and director of the Texas Neurofibromatosis Foundation. He brings first hand knowledge of Anvirzel ™ and its effects through his personal observations of family and friends receiving Anvirzel™ therapy.</p>
            
<h4>Charles R. Hughes, Branding and Marketing Advisor</h4><br/>
<p>Mr. Hughes is the founder and presently operates Brand Rules, LLC, located in Severna Park, Maryland. Brand Rules is a consulting consortium that applies decades of experience to create, shape, and sustain successful brands. It guides clients in developing a differentiating market strategy, an engaged culture, and effective execution of product, marketing, and retail. Clients include Hyundai, Kia, Ford, and Zodiac as well as start-ups, not-for-profits, and marketing companies. Mr. Hughes was the founder, President, and CEO of Land Rover North America, BMW Group located in Lanham, Maryland. As Chief Executive Officer, he presided over a $1 billion, 24,000-unit sales enterprise that successfully introduced the first Range Rover then Land Rover to the North American market. NBI believes that Mr. Hughes’ experience with successfully building, branding, marketing, and expanding start-ups will be invaluable to NBI.</p>
    </p>       
		</div>
	</div>	
 
<?php include('../deepPageFooter.php'); ?>
